The pathogen Clostridioides difficile (C. difficile) is naturally present in the intestines of many people. When present in ...

A retrospective Chinese cohort study finds that serial changes in PCR cycle threshold values for the tcdB gene correlate with ...

The researchers wrote that their findings showcase the need for close monitoring of patients and for effective treatments for those with recurrent infection, which occurs in 15%-30% of all patients ...

A new study from the University of Birmingham has shown that fecal microbiota transplants (FMT) are highly successful in treating patients with Clostridioides difficile (C. diff) infection. A new ...

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...

In a new Annals "Beyond the Guidelines" feature, an infectious diseases specialist and a gastroenterologist discuss the benefits and risks of different treatment approaches for Clostridioides ...

Treatment with ridinilazone was found to significantly decrease the rate of recurrent Clostridioides difficile infection (CDI) compared with vancomycin. Treatment with ridinilazone was found to ...

Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal cost-effective ...

Newswise — Every time we take antibiotics—whether it’s for strep throat, urinary tract infections, or pneumonia —there is a slim chance that “bad” bacteria can move in and wreak havoc on our digestive ...

Clostridium bacteria, computer illustration. Clostridia are spore-forming bacteria that include several human pathogenic species, C. difficile, C. tetani, C. botulinum, C. perfringens, and others. C.

Please provide your email address to receive an email when new articles are posted on . New guidelines issued in 2021 stated a preference for fidaxomicin as first-line treatment for Clostridioides ...

A new review in Gut Pathogens argues that SARS-CoV-2 infection and COVID-19 care pathways may create gut conditions ...